NEW YORK, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.
Allergan plc (NYSE: AGN) Class Period: February 24, 2017 - December 19, 2018 Lead Plaintiff Deadline: February 19, 2019 Join the action: https://www.zlk.com/pslra-1/allergan-plc-loss-form?wire=3
The lawsuit alleges: Allergan plc made materially false and/or misleading statements and/or failed to disclose that: (i) textured breast implants manufactured by Allergan were linked to ALCL; (ii) the foregoing link to cancer, when revealed, would foreseeably force Allergan to recall those textured breast implants from the market; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
To learn more about the Allergan plc class action contact jlevi@levikorsinsky.com .
Activision Blizzard, Inc. (NASDAQ: ATVI) Class Period: August 2, 2018 - January 10, 2019 Lead Plaintiff Deadline: March 19, 2019 Join the action: https://www.zlk.com/pslra-1/activision-blizza...orm?wire=3
The lawsuit alleges that, during the class period, Activision Blizzard, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the termination of Activision Blizzard and Bungie's partnership, giving Bungie full publishing rights and responsibilities for the Destiny franchise, was imminent; (ii) the termination of the two companies' relationship would foreseeably have a significant negative impact on Activision Blizzard's revenues; and (iii) as a result, Activision Blizzard's public statements were materially false and misleading at all relevant times.
To learn more about the Activision Blizzard, Inc. class action contact jlevi@levikorsinsky.com .
Tyme Technologies, Inc. (NASDAQCM: TYME) Class Period: March 14, 2018 - January 18, 2019 Lead Plaintiff Deadline: March 29, 2019 Join the action: https://www.zlk.com/pslra-1/tyme-technologies...orm?wire=3
The lawsuit alleges: Tyme Technologies, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Tyme had not adequately designed the Phase II Study to present reliable results on the efficacy of SM-88 on pancreatic cancer; (ii) Tyme had failed to include an appropriate control group in its open-label Phase II clinical trial for SM-88; (iii) the omission of an appropriate control group distorted the reliability of data showing the efficacy of SM-88 in the Phase II Study; and (iv) as a result, Tyme’s public statements were materially false and misleading at all relevant times.
To learn more about the Tyme Technologies, Inc. class action contact jlevi@levikorsinsky.com .
General Electric Company (NYSE: GE) Class Period: December 27, 2017 - October 29, 2018 Lead Plaintiff Deadline: April 2, 2019 Join the action: https://www.zlk.com/pslra-1/general-electric-...orm?wire=3
The lawsuit alleges that, during the class period, General Electric Company made materially false and/or misleading statements and/or failed to disclose that: (i) the design and technology of GE Power’s flagship gas turbines were structurally flawed as they were plagued with an oxidation problem that caused the blades in the H-Class gas turbines to fail; (ii) GE Power’s goodwill was materially overstated, in large part because of such structural issues; (iii) the Company lacked adequate internal and financial controls; and (iv) as a result of the foregoing, Defendant’s public statements were materially false and/or misleading and/or lacked a reasonable basis.
To learn more about the General Electric Company class action contact jlevi@levikorsinsky.com .
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 55 Broadway, 10th Floor New York, NY 10006 jlevi@levikorsinsky.com Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
